Novel microsimulation model of tobacco use behaviours and outcomes: calibration and validation in a US population.

Krishna P ReddyAlexander J B BulteelDouglas E LevyPamela TorolaEmily P HyleTaige HouBenjamin OsherLiyang YuFatma M SheblA David PaltielKenneth A FreedbergMilton C WeinsteinNancy A RigottiRochelle P Walensky

Published in: BMJ open (2020)

The STOP model, with relapse included, performed well when validated to US smoking prevalence and mortality. STOP provides a flexible framework for policy-relevant analysis of tobacco and nicotine product use.

Keyphrases

smoking cessation
risk factors
public health
type diabetes
metabolic syndrome
coronary artery disease
free survival
clinical evaluation